Cytomegalovirus and pregnancy

Area of Science:

• Virology
• Infectious Diseases
• Public Health

Background:

• Cytomegalovirus (CMV) is the leading cause of congenital infections globally, affecting about 1% of newborns.
• Congenital CMV infection can lead to significant long-term sequelae, including intellectual disability and hearing loss, particularly in symptomatic infants.
• Over 90% of symptomatic cases or those resulting in sequelae stem from primary maternal CMV infection during pregnancy.

Purpose of the Study:

• To review the epidemiology of congenital Cytomegalovirus (CMV) infection.
• To identify high-risk populations for primary maternal CMV infection.
• To discuss the implications for CMV vaccine development and intervention strategies.

Main Methods:

• Literature review and analysis of existing epidemiological data on Cytomegalovirus (CMV) prevalence.
• Identification of risk factors and transmission routes for primary maternal CMV infection.
• Evaluation of potential intervention strategies and vaccine development needs.

Main Results:

• Primary maternal CMV infection during pregnancy carries a 10-20% risk of infant handicaps.
• High-risk groups for CMV acquisition include day-care workers (10-20% annual rate) and mothers of young children (50% annual rate).
• Adolescents also represent a population with potentially high CMV infection rates during pregnancy.

Conclusions:

• Congenital Cytomegalovirus (CMV) poses a significant global health challenge, necessitating preventative measures.
• The high incidence in specific demographics underscores the urgency for a CMV vaccine.
• Intervention strategies are needed for high-risk pregnancies pending vaccine availability.